TW200743492A - Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells - Google Patents

Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells

Info

Publication number
TW200743492A
TW200743492A TW095119069A TW95119069A TW200743492A TW 200743492 A TW200743492 A TW 200743492A TW 095119069 A TW095119069 A TW 095119069A TW 95119069 A TW95119069 A TW 95119069A TW 200743492 A TW200743492 A TW 200743492A
Authority
TW
Taiwan
Prior art keywords
cartilage cells
hyaluronic acid
proliferation
oxidation
acid used
Prior art date
Application number
TW095119069A
Other languages
Chinese (zh)
Inventor
Ching-Chuan Jiang
jian-ting Zheng
huan-qing Xu
Original Assignee
Ching-Chuan Jiang
jian-ting Zheng
huan-qing Xu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ching-Chuan Jiang, jian-ting Zheng, huan-qing Xu filed Critical Ching-Chuan Jiang
Priority to TW095119069A priority Critical patent/TW200743492A/en
Priority to JP2007128251A priority patent/JP2007314531A/en
Publication of TW200743492A publication Critical patent/TW200743492A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

This invention is related to the purpose of using hyaluronic acid (also named uronic acid) to improve the oxidation damage to cartilage cells and further promote the proliferation of cartilage cells. More especially, this invention is related to the purpose of using hyaluronic acid with its molecule weight ranging between 600 to 1200 thousand Dalton to protect cartilage cells from damage of reactive oxygen and promote the proliferation of cartilage cells. This invention is also related to the purpose of using hyaluronic acid to manufacture medicines for treating or preventing arthritis and oral food or drinks for improving arthritis symptoms.
TW095119069A 2006-05-29 2006-05-29 Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells TW200743492A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW095119069A TW200743492A (en) 2006-05-29 2006-05-29 Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells
JP2007128251A JP2007314531A (en) 2006-05-29 2007-05-14 Hyaluronic acid used in application of anti-oxidation and hyperplasia of chondrocyte

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW095119069A TW200743492A (en) 2006-05-29 2006-05-29 Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells

Publications (1)

Publication Number Publication Date
TW200743492A true TW200743492A (en) 2007-12-01

Family

ID=38848727

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095119069A TW200743492A (en) 2006-05-29 2006-05-29 Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells

Country Status (2)

Country Link
JP (1) JP2007314531A (en)
TW (1) TW200743492A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8462765B2 (en) * 2008-08-20 2013-06-11 Qualcomm Incorporated Method and apparatus to perform ranging operations for wireless stations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391864B1 (en) * 1998-08-19 2002-05-21 Joint Juice, Inc. Food supplement containing a cartilage supplement
MXPA01011542A (en) * 2001-11-13 2003-05-22 Alcon Inc Regeneration of articular cartilage damaged by osteoarthritis i and ii, by means of intra-articular application of sodium hyaluronate and chondroitin sulphate in a gel carrier.

Also Published As

Publication number Publication date
JP2007314531A (en) 2007-12-06

Similar Documents

Publication Publication Date Title
ATE488242T1 (en) ANTI-INFLAMMATORY AND/OR ANALGESIC COMPOSITION FOR THE INTESTINAL CONTAINING BRANCHED MALTODEXTRINS
MX2009005455A (en) (r)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs.
MY159360A (en) Barley and uses thereof
MY155418A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
NZ620326A (en) Cd37 immunotherapeutic combination therapies and uses thereof
WO2011060304A3 (en) Oxygen scavengers, compositions comprising the scavengers, and artcles made from the compositions
WO2010144344A3 (en) Melanocortin receptor-specific peptides
IN2012DN01233A (en)
MX2010006033A (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof.
IL188475A0 (en) Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors
TN2010000086A1 (en) Antiviral composition comprising a sulfated polysaccharide
IL172773A (en) Formulations for the treatment of arthritis conditions
UA91848C2 (en) Diosmetin derivatives for the treatment and prevention of thrombotic pathologies
GB0714228D0 (en) Oral compositions. Their preparation and use
MY158106A (en) Inhibitors of e1 activating enzymes
MX346003B (en) Antibacterial oral composition.
AU2010230585A8 (en) Autotaxin inhibitors
MY138708A (en) Biaryloxymethylarenecarboxylic acids
MY149606A (en) Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
IN2012DN05020A (en)
TW200602042A (en) Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
UA102238C2 (en) 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof
TW200801032A (en) Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
GB2476418A (en) A medicinal product and treatment
TW200743492A (en) Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells